Hypophosphatasia - 25 Studies Found
Recruiting |
: Biomarker for Hypophosphatasia Disease :
|
Completed |
: Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09 :
: 2014-09-05 : Biological: Retrospective Case Only |
NOT_YET_RECRUITING |
: Phase 3 Study of ALXN1850 in Treatment-Na�ve Pediatric Participants With HPP : Hypophosphatasia : 2024-10-31 : Participants will receive a ALXN1850 via subcutaneous (SC) injection. |
NOT_YET_RECRUITING |
: Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa : Hypophosphatasia : 2024-10-31 : ALXN1850 will be administered via subcutaneous (SC) injection. |
NOT_YET_RECRUITING |
: Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa : Hypophosphatasia : 2024-10-31 : ALXN1850 will be administered via subcutaneous (SC) injection. |